Literature DB >> 31393173

Disparities and Delay in the Use of Guideline-Based Antiretroviral Therapy for Treatment of Pregnant Women with HIV in the Southeast United States.

Ellery R Cohn1, Jeffrey E Korte2, Gweneth B Lazenby3.   

Abstract

Entities:  

Year:  2019        PMID： 31393173      PMCID： PMC6745527          DOI： 10.1089/apc.2019.0147

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  10 in total

1.  US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.

Authors: 
Journal:  HIV Clin Trials       Date:  2000 Sep-Oct

2.  Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.

Authors:  Josep M Llibre; Chien-Ching Hung; Cynthia Brinson; Francesco Castelli; Pierre-Marie Girard; Lesley P Kahl; Elizabeth A Blair; Kostas Angelis; Brian Wynne; Kati Vandermeulen; Mark Underwood; Kim Smith; Martin Gartland; Michael Aboud
Journal:  Lancet       Date:  2018-01-06       Impact factor: 79.321

3.  Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.

Authors:  Jennifer M Cocohoba; Keri N Althoff; Rebecca Godfrey; Frank J Palella; Ruth M Greenblatt
Journal:  AIDS Care       Date:  2011-07-06

4.  Revised surveillance case definition for HIV infection--United States, 2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-04-11

5.  Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Authors:  Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

6.  Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

Authors:  Roland Tubiana; Jerome Le Chenadec; Christine Rouzioux; Laurent Mandelbrot; Karima Hamrene; Catherine Dollfus; Albert Faye; Constance Delaugerre; Stephane Blanche; Josiane Warszawski
Journal:  Clin Infect Dis       Date:  2010-02-15       Impact factor: 9.079

7.  Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

Authors:  Jennifer Cocohoba; Qiong J Wang; Christopher Cox; Stephen J Gange; Mardge Cohen; Marshall Glesby; Jack A DeHovitz; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

8.  The Impact of Delivery in a Rural County on a Cohort of Women Living with HIV Infection and Their Infants.

Authors:  Gweneth B Lazenby; Anna M Powell; Scott A Sullivan; David E Soper
Journal:  J Rural Health       Date:  2018-07-16       Impact factor: 4.333

9.  A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.

Authors:  Gilles Wandeler; Olivia Keiser; Bernard Hirschel; Huldrych F Günthard; Enos Bernasconi; Manuel Battegay; Olivier Clerc; Pietro L Vernazza; Hansjakob Furrer
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

10.  Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.

Authors:  Linda Beer; Christine L Mattson; Heather Bradley; Jacek Skarbinski
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.